Fever in the neutropenic host

S. J. Chanock; P. A. Pizzo

doi:10.1016/S0891-5520(05)70326-3

Fever in the neutropenic host

S. J. Chanock, P. A. Pizzo

School of Medicine

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Fever in the neutropenic patient following myelosuppressive chemotherapy is a medical emergency. Appropriate antimicrobial therapy can dramatically reduce infection-related morbidity and mortality. This article reviews the rationale and methodology of treatment as well as its applicability to other neutropenic states. The utility of adjunct therapy with granulocyte-stimulating compounds is also discussed.

Original language	English (US)
Pages (from-to)	777-796
Number of pages	20
Journal	Infectious disease clinics of North America
Volume	10
Issue number	4
DOIs	https://doi.org/10.1016/S0891-5520(05)70326-3
State	Published - Jan 1 1996

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1016/S0891-5520(05)70326-3

Cite this

@article{31d82d82e8f44d44a4f687f6c407a703,

title = "Fever in the neutropenic host",

abstract = "Fever in the neutropenic patient following myelosuppressive chemotherapy is a medical emergency. Appropriate antimicrobial therapy can dramatically reduce infection-related morbidity and mortality. This article reviews the rationale and methodology of treatment as well as its applicability to other neutropenic states. The utility of adjunct therapy with granulocyte-stimulating compounds is also discussed.",

author = "Chanock, {S. J.} and Pizzo, {P. A.}",

year = "1996",

month = jan,

day = "1",

doi = "10.1016/S0891-5520(05)70326-3",

language = "English (US)",

volume = "10",

pages = "777--796",

journal = "Infectious disease clinics of North America",

issn = "0891-5520",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Fever in the neutropenic host

AU - Chanock, S. J.

AU - Pizzo, P. A.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Fever in the neutropenic patient following myelosuppressive chemotherapy is a medical emergency. Appropriate antimicrobial therapy can dramatically reduce infection-related morbidity and mortality. This article reviews the rationale and methodology of treatment as well as its applicability to other neutropenic states. The utility of adjunct therapy with granulocyte-stimulating compounds is also discussed.

AB - Fever in the neutropenic patient following myelosuppressive chemotherapy is a medical emergency. Appropriate antimicrobial therapy can dramatically reduce infection-related morbidity and mortality. This article reviews the rationale and methodology of treatment as well as its applicability to other neutropenic states. The utility of adjunct therapy with granulocyte-stimulating compounds is also discussed.

UR - http://www.scopus.com/inward/record.url?scp=0030449850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030449850&partnerID=8YFLogxK

U2 - 10.1016/S0891-5520(05)70326-3

DO - 10.1016/S0891-5520(05)70326-3

M3 - Article

C2 - 8958168

AN - SCOPUS:0030449850

SN - 0891-5520

VL - 10

SP - 777

EP - 796

JO - Infectious disease clinics of North America

JF - Infectious disease clinics of North America

IS - 4

ER -

Fever in the neutropenic host

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this